Archive: Bo Huang joins Department of Pharmaceutical Chemistry
New UCSF Faculty, October 2009
University of California San Francisco
Give to UCSFNew UCSF Faculty, October 2009
New UCSF Faculty, October 2009
New UCSF Faculty, October 2009
New UCSF Faculty, October 2009
UCSF has launched a website to serve as a source of information for faculty, staff and trainees, who have questions about the medical group’s new relationship with Hill Physicians Medical Group.
New UCSF Faculty, October 2009
Dean Schillinger, director of the UCSF Center for Vulnerable Populations (CVP) at San Francisco General Hospital, received a national award for research leading to better communication in health care.
A recent two-day symposium at UCSF offered leading stem cell experts a chance to talk shop and form new alliances in the fight against neurological disorders.
From anxiety to exhilaration to burgers with the boss, the 14 members of Elizabeth Blackburn's lab share the exciting hours surrounding the Oct. 5 Nobel Prize announcement.
The University of California, San Francisco has been designated to lead a new consortium that will study a group of severe immune disorders known as primary immunodeficiencies and aims to improve treatment for these often life-threatening diseases. The Primary Immune Deficiency Treatment Consortium comprises 13 centers throughout the United States and has a $6.25 million funding commitment over five years from the National Institutes of Health.
A collaboration between scientists at Vanderbilt University and the University of California, San Francisco has led to the first direct information about the molecular structure of prions. In addition, the study has revealed surprisingly large structural differences between natural prions and the closest synthetic analogs that scientists have created in the lab.
Actress Kathleen Turner will visit the research labs of the Rosalind Russell Arthritis Center at UCSF to gain a better understanding of the impact of autoimmune diseases and to learn firsthand about ongoing UCSF research for potential therapies.
Symbolizing a major triumph for UCSF, the University of California and the scientific community at large, molecular biologist Elizabeth Blackburn, PhD, became UCSF's fourth scientist to be tapped to receive the prestigious Nobel Prize in Physiology or Medicine.
Elizabeth Blackburn, professor emeritus in the Department of Biochemistry and Biophysics at UC San Francisco, received the 2009 Nobel Prize in Physiology or Medicine. Her research on telomeres, tiny
A roundup of coverage on Elizabeth Blackburn's Nobel Prize in Physiology or Medicine.
Molecular biologist Elizabeth H. Blackburn, PhD, 60, of the University of California, San Francisco, received the 2009 Nobel Prize in Physiology or Medicine on December 10th, 2009 in Stockholm, Sweden.
Molecular biologist Elizabeth H. Blackburn, PhD, 60, of the University of California, San Francisco, today was named to receive the 2009 Nobel Prize in Physiology or Medicine.
The 2009 Nobel Prize in Physiology or Medicine, awarded today to UCSF’s Elizabeth Blackburn, PhD – along with Carol Greider, PhD, of Johns Hopkins University School of Medicine and Jack Szostak, PhD, of Massachusetts General Hospital – recognizes the importance of the most fundamental kind of basic biological science.
Scientist Elizabeth H. Blackburn, PhD, 60, of the University of California, San Francisco was named today (Oct. 5, 2009) to receive the 2009 Nobel Prize in Physiology or Medicine.
UCSF's Elizabeth Blackburn, PhD, addressed the media during a news conference at the Mission Bay campus on Oct. 5, held in recognition of the announcement that she received the 2009 Nobel Prize in Physiology or Medicine
Experts will explore the often sensational stories about gender – including the recent “sex testing” of intersex South African runner Caster Semenya – in a new series at UCSF.
Kick-off event for the 20th annual Macy’s Christmas Tree Lighting benefiting UCSF Children’s Hospital. The celebration will feature a visit from Honorary Chair and San Francisco Giants pitcher Barry Zito, as well as face painting, refreshments, and elves to entertain young patients. Great photo, audio and video opportunities.
Opening today at Mission Bay, the UCSF Orthopaedic Institute is a major new center that is the most comprehensive location in the Bay Area for outpatient treatment, research and training in musculoskeletal conditions, injuries and sports medicine.
The newly expanded BreastCancerTrials.org provides a patient-controlled, custom-tailored experience that is earning rave reviews from users.
Territorial behavior in male mice might be linked to more “girl-power” than ever suspected, according to new findings at UCSF. For the first time, researchers have identified networks of nerve cells in the brain that are associated with how male mice defend their territory and have shown that these cells are controlled by the female hormone estrogen.
UCSF is celebrating the grand opening of its new Orthopaedic Institute, a major new facility for treating patients and translational research.